GIT Transit Time & SIBO: Accurate Testing Starts with Timing

What is GI transit time?

Gastrointestinal (GI) transit time is the duration required for ingested material to pass through the digestive tract from ingestion to excretion. This parameter plays a critical role in regulating nutrient absorption, microbial activity, and the accumulation or clearance of metabolic byproducts within the gut. When transit time is too slow or too fast, it can disrupt gastrointestinal homeostasis and contribute to conditions such as dysbiosis and small intestinal bacterial overgrowth (SIBO).

What impacts gi transit time?

GI transit time is influenced by a range of physiological and lifestyle factors, including:

• Metabolic rate
• Medications (e.g., antibiotics, opioids, proton pump inhibitors)
• Dietary composition (fiber intake, fat content)
• Hydration status
• Gut microbiome composition
• Physical activity levels
• Stress
• Inflammation

Clinically, stool frequency and consistency are often used as practical indicators of transit time. Some individuals perform a corn or “beet challenge test,” where they eat beets or corn and see how long it takes for it to show up in their stool (color and texture is very visible).

How is sibo related to transit time?

Small Intestinal Bacterial Overgrowth (SIBO) occurs when bacteria, typically confined to the large intestine, proliferate within the small intestine. Transit time plays a key role in this process.

Delayed transit can promote bacterial stasis, allowing microbes to colonize areas of the small intestine where they are not normally present. Conversely, excessively rapid transit may impair digestion and absorption, further altering the gut environment and microbial balance.

How is sibo traditionally assessed?

SIBO is evaluated using breath testing, which measures Hydrogen and Methane gases produced by bacterial fermentation. During testing, a patient consumes a substrate such as lactulose or glucose, and breath samples are collected at timed intervals.

As this substrate passes through the gastrointestinal tract it will eventually come into contact with gut bacteria either in the small intestine (if they are present) or in the large intestine. The bacteria consume the substrate and release Hydrogen and Methane as a byproduct.

By measuring the two gases at periodic intervals we can assess the absence/presence of SIBO. Note that we measure carbon dioxide too as a control gas to ensure there is adequate alveolar air to have an accurate measure of the other gases, and like creatinine standardization to be able to compare across people.

Glucose and lactulose test for SIBO. Fructose tests are for fructose intolerance/ malabsorption.

Breath Test Comparison Chart

Breath Test Comparison Chart. Courtesy of Dr. Racheal Onah BSc. ND MRN.

Typical interpretation patterns:

• Normal (Negative Result):
  This indicated that there is little increase in the Hydrogen and Methane levels over the course of the 6 -8 timed samples. This would be indicative that there are either no bacteria present or relatively low numbers of bacteria present.
• Abnormal (Positive Result):
  An abnormal result is defined by a rise in Hydrogen and/or Methane levels above established thresholds compared to the lowest preceding value within the first 120 minutes. Increases of ≥ 20 ppm for Hydrogen, ≥ 12 ppm for Methane, or ≥ 15 ppm for combined gases may suggest bacterial overgrowth, depending on clinical context.

*It is important to note that breath testing does not identify the specific organisms involved.

wHich microorganisms are involved in sibo? 

Common Hydrogen-Producing Bacteria:

• Escherichia coli
• Klebsiella spp.
• Enterobacter spp.
• Citrobacter spp.
• Proteus spp.
• Clostridium spp.
• Bacteroides spp.
• Lactobacillus spp.
• Streptococcus spp.

Common Methane-Producing Microorganisms:

• Methanobrevibacter smithii
• Methanosphaera stadtmanae

While these organisms contribute to gas production, identifying their presence and relative abundance requires more advanced microbiome assessment.

A follow up advanced microbiome test would identify the offending organisms and what antimicrobials to use to reduce their numbers

Clinical considerations

When evaluating patients with suspected SIBO or motility-related dysfunction, clinicians should consider:

• The role of transit time in symptom development
• Underlying drivers such as diet, stress, and inflammation
• The limitations of single-test approaches
• The importance of correlating test results with clinical presentation

Addressing both motility and microbial balance is often necessary to achieve sustained symptom improvement.

in Conclusion

GI transit time is a fundamental determinant of digestive health, influencing microbial activity, nutrient absorption, and overall gut function. Disruptions in transit time can create an environment that supports bacterial overgrowth and contributes to a wide range of gastrointestinal symptoms.

While breath testing provides one method of assessing SIBO, a more comprehensive approach, integrating functional and microbiome-based insights, can offer a deeper understanding of underlying dysfunction and guide more effective clinical decision-making.

Additional Resources

Mayo Clinic Staff. (2024, November 11). Small intestinal bacterial overgrowth (SIBO). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/small-intestinal-bacterial-overgrowth/symptoms-causes/syc-20370168

SIBO: What is it and do you have it? (2020, August 25). NewYork-Presbyterian. https://www.nyp.org/healthmatters/sibo-what-is-it-and-do-you-have-it

Roland, B. C., Ciarleglio, M. M., Clarke, J. O., Semler, J. R., Tomakin, E., Mullin, G. E., & Pasricha, P. J. (2015). Small intestinal transit time is delayed in small intestinal bacterial overgrowth. Journal of Clinical Gastroenterology, 49(7), 571–576. https://doi.org/10.1097/MCG.0000000000000257